Literature DB >> 26822618

Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area.

Shuenn-Nan Chiu1, Pei-Lan Shao2, Hui-Chi Chen3, Ming-Tai Lin1, Li-Min Huang1, Feng-Yu Kao4, San-Kuei Huang4, Jou-Kou Wang1, Mei-Hwan Wu5.   

Abstract

OBJECTIVE: To compare the risk of respiratory syncytial virus (RSV)-associated hospitalization and analyze the epidemiology of RSV infection in patients with cyanotic and acyanotic congenital heart disease (CHD), we analyzed the nationwide health insurance database from 2005-2010. STUDY
DESIGN: This study included 1050 patients with cyanotic CHD and 7077 patients with acyanotic CHD. Patients with acyanotic CHD were further classified into hemodynamically significant (hs)-acyanotic and non-hs-acyanotic groups according to whether they underwent surgery or took at least 2 anticongestive medications.
RESULTS: RSV-associated hospitalization was higher in the cyanotic group than in hs-acyanotic and non-hs-acyanotic groups both before 1 year of age (4.8% vs 2.1% vs 1.5%, P < .001) and between 1 and 2 years of age (0.9% vs 0.56% vs 0.14%, P = .003). The hospitalization duration, intensive care, ventilator support prevalence, hospitalization cost, and mortality rate were significantly higher in the cyanotic group than in the other 2 groups. Logistic regression revealed that cyanotic CHD was the most significant risk factor for the ventilator support and RSV-associated mortality. In both patients with cyanotic and acyanotic CHD, RSV-associated hospitalization rate was higher in patients aged younger than 1 year and in spring and autumn in Taiwan, a subtropical country.
CONCLUSIONS: The results show that patients with cyanotic CHD have a higher risk of severe RSV infection than do those with acyanotic CHD. RSV prophylaxis is more important and may reduce costs more for patients with cyanotic CHD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26822618     DOI: 10.1016/j.jpeds.2015.12.029

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia.

Authors:  C Morley; K Grimwood; S Maloney; R S Ware
Journal:  Epidemiol Infect       Date:  2018-03-21       Impact factor: 4.434

2.  Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease.

Authors:  Shuenn-Nan Chiu; Ching-Chia Wang; Ming-Tai Lin; Chun-An Chen; Chun-Wei Lu; Yu-Chuan Hua; Jing-Ming Wu; Mei-Hwan Wu; Jou-Kou Wang
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418

3.  Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.

Authors:  B Resch; S Kurath-Koller; J Hahn; W Raith; M Köstenberger; A Gamillscheg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-28       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.